Tourmaline Bio, Inc. (TRML)
(Delayed Data from NSDQ)
$15.68 USD
-0.32 (-2.00%)
Updated Apr 26, 2024 04:00 PM ET
3-Hold of 5 3
D Value A Growth B Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/20/2024
Time: -- |
3/2024 | $-0.68 | 0.00% |
Earnings Summary
For their last quarter, Tourmaline Bio, Inc. (TRML) reported earnings of -$0.81 per share, missing the Zacks Consensus Estimate of -$0.75 per share. This reflects a negative earnings surprise of 8.00%. Look out for TRML's next earnings release expected on May 20, 2024. For the next earning release, we expect the company to report earnings of -$0.68 per share, reflecting a year-over-year increase of 87.41%.
Earnings History
Price & Consensus
Zacks News for TRML
Here's What Could Help Tourmaline Bio, Inc. (TRML) Maintain Its Recent Price Strength
TRML: What are Zacks experts saying now?
Zacks Private Portfolio Services